Compounds > 9,10-anthraquinone 2-carboxylic acid
Page last updated: 2024-08-24

9,10-anthraquinone 2-carboxylic acid and Breast Neoplasms

9,10-anthraquinone 2-carboxylic acid has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, C; Cryderman, DE; Fagan, RL; Kopelovich, L; Wallrath, LL1
Bielawska, A; Bielawski, K; Pałka, J1

Other Studies

2 other study(ies) available for 9,10-anthraquinone 2-carboxylic acid and Breast Neoplasms

ArticleYear
Laccaic acid A is a direct, DNA-competitive inhibitor of DNA methyltransferase 1.
    The Journal of biological chemistry, 2013, Aug-16, Volume: 288, Issue:33

    Topics: Aminoquinolines; Anthraquinones; Azacitidine; Azo Compounds; Base Sequence; Breast Neoplasms; Decitabine; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Replication; Enzyme Inhibitors; Female; Fluorometry; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Pyrimidines; Reproducibility of Results; Signal Transduction; Transition Temperature

2013
Cytotoxicity activity of L-proline analogues of anthraquinone-2-carboxylic acid in breast cancer MCF-7 cells.
    Folia histochemica et cytobiologica, 2001, Volume: 39 Suppl 2

    Topics: Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Carboxylic Acids; Female; Humans; Prodrugs; Proline; Thymidine; Tritium; Tumor Cells, Cultured

2001